1,5-Diarylpyrazole and vanillin hybrids: Synthesis, biological activity and DFT studies

Eur J Med Chem. 2015 Jul 15:100:106-18. doi: 10.1016/j.ejmech.2015.06.010. Epub 2015 Jun 5.

Abstract

Herein, we report the design and synthesis of 13 diarylpyrazole hybrids with vanillin constructed as dual compounds against oxidative stress and diabetes. Compounds were tested in two different antioxidant assays. It was found that all compounds showed an important antioxidant activity in both DPPH and ORAC models and the activity was even more remarkable than vanillin. In addition, the hypoglycemic effect of compounds 1, 2, 4 and 12 was evaluated. Interestingly, compound 1 had the most potent hypoglycemic effect with a glycemia reduction of 71%, which was higher than rimonabant. Finally, a DFT study to propose a reasonable antioxidant mechanism is detailed. Both thermodynamic and kinetic studies indicated that the most feasible mechanism consists in the HAT abstraction of the phenolic hydrogen due to the formation of an stable transition state through the most rapid and exergonic path, while the SPLET mechanism is the most significant at higher pH values.

Keywords: Antioxidant capacity; DFT calculations; Diarylpyrazole hybrids; Vanillin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / chemical synthesis
  • Antioxidants / chemistry
  • Antioxidants / pharmacology*
  • Benzaldehydes / chemistry
  • Benzaldehydes / pharmacology
  • Diabetes Mellitus, Experimental / drug therapy*
  • Dose-Response Relationship, Drug
  • Hypoglycemia / drug therapy*
  • Hypoglycemic Agents / chemical synthesis
  • Hypoglycemic Agents / chemistry
  • Hypoglycemic Agents / pharmacology*
  • Molecular Structure
  • Oxidative Stress / drug effects
  • Pyrazoles / chemistry
  • Pyrazoles / pharmacology*
  • Quantum Theory*
  • Rats
  • Structure-Activity Relationship

Substances

  • Antioxidants
  • Benzaldehydes
  • Hypoglycemic Agents
  • Pyrazoles
  • vanillin